Ondansetron versus a chlorpromazine and dexamethasone combination for the prevention of nausea and vomiting: A prospective, randomised study to assess efficacy, cost effectiveness and quality of life following single- fraction radiotherapy

Supportive Care in Cancer

Volumn 5, Issue 6, 1997, Pages 500-503

  Sykes, A J ^a   Kiltie, A E ^a   Stewart, A L ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Chlorpromazine; Dexamethasone; Emesis; Ondansetron; Radiotherapy

Indexed keywords

ANTIEMETIC AGENT; CHLORPROMAZINE; DEXAMETHASONE; ONDANSETRON; SEROTONIN 3 ANTAGONIST;

ARTICLE; BONE METASTASIS; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VOMITING;

ADULT; ANTIEMETICS; CHLORPROMAZINE; COST-BENEFIT ANALYSIS; DEXAMETHASONE; DRUG THERAPY, COMBINATION; HEMIBODY IRRADIATION; HUMANS; NAUSEA; ONDANSETRON; PROSPECTIVE STUDIES; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; VOMITING;

EID: 0030717168     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005200050119     Document Type: Article

References (8)

1. Collis C, Priestman TJ, Priestman S, et al (1991) The final assessment of a randomised double blind comparative study of ondansetron vs. metoclopramide in the prevention of vomiting following high dose upper abdominal irradiation. Clin Oncol 3:241-243
2. Danjoux CE, Rider WD, Fitzpatrick PJ (1979) The acute radiation syndrome. A memorial to William Michael Court-Brown. Clin Radiol 30:581-584
3. Gandara DR (1991) Progress in the control of acute and delayed emesis induced by cisplatin. Eur J Cancer 27 [Suppl 1]: S9-11
4. Priestman TJ, Roberts JT, Lucraft H, et al (1990) Results of a randomised, double blind comparative study of ondansetron and metoclopramide in the prevention of nausea and vomiting following high dose upper abdominal irradiation. Clin Oncol 2:71-75
5. Priestman TJ, Roberts JT, Upadhyaya BK (1993) A prospective randomised double blind trial comparing ondansetron versus prochlorperazine for the prevention of nausea and vomiting in patients undergoing fractionated radiotherapy. Clin Oncol 5:358-363
6. Roberts JT, Priestman TJ (1993) A review of ondansetron in the management of radiotherapy induced emesis. Oncology 50:173-179
7. Salazar OM, Rubin P, Keller B, et al (1988) Systemic (half-body) radiation therapy: response to toxicity. Int J Radiat Biol Phys 4:937-950
8. Schipper H (1984) Measuring the quality of life of cancer patients: the functional living index cancer: development and validation. J Clin Oncol 2:412-483